This approval enhances Alembic Pharma’s portfolio, which now totals 216 ANDAs from the USFDA, including 188 final and 28 ...

Alembic Pharma share price surged after the United States Food and Drug Administration (USFDA) gave final approval for ...

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug ...

Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Alcaftadine Ophthalmic Solution.

Alembic has a cumulative total of 216 ANDA approvals (189 final approvals and 27 tentative approvals) from USFDA.

The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.

This is the first step in the direction of the budget announcement this year to provide internships to one crore youth in the ...

Mahindra Group, Max Life Insurance, and Alembic Pharmaceuticals are leading internships under a new central scheme, with ...

Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June ...

These companies have already listed 1,077 internship positions across sectors including auto, pharma, and agriculture.

This approval adds to Alembic Pharma's growing portfolio, which now includes 216 ANDA approvals from the USFDA, comprising ...

The approved ANDA is therapeutically equivalent to GlaxoSmithKline LLC's Lamictal XR extended-release tablets in strength of ...